The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
1 other identifier
interventional
5,215
17 countries
30
Brief Summary
The purpose of the study is to test whether the health care provider access and training in CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness), would facilitate timely and error free best-practice delivery and minimize preventable death and costly complications in critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
30 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2013
CompletedFirst Posted
Study publicly available on registry
November 1, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedAugust 20, 2018
August 1, 2018
4.1 years
October 23, 2013
August 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence to best critical care practices
Adherence to best practice in initial evaluation and treatment of critically ill medical and surgical patients Appropriate shock resuscitation Appropriate sepsis treatment Appropriate mechanical ventilation Appropriate peptic ulcer, deep vein thrombosis and infectious disease prophylaxis
Participants will be followed for the duration of ICU stay, an expected average of 2 weeks
ICU and hospital lengths of stay
Patient will be followed till they get discharged from hospital for whatever length they stay.
Participants will be followed for the duration of hospital stay, an expected average of 8 weeks
Secondary Outcomes (1)
Mortality for 4 weeks
Participants will be followed for the duration of 4 weeks and hospital discharge (up to 10 weeks post discharge)
Study Arms (1)
Baseline arm
OTHERbaseline data (50 patients or 3 months per center)
Interventions
This study is about training and implementation of best critical care practices in the international ICUs with variable resources facilitated by access to a specifically designed electronic checklist
Eligibility Criteria
You may qualify if:
- All adult (≥ 18 years) patients admitted for the first time to the participating ICUs will be included.
You may not qualify if:
- Not critically Ill, admitted for low risk monitoring, planned ICU admissions for routine postoperative surveillance for less than 24 hours after uncomplicated surgery, readmission and transferred from outside ICU.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (30)
Gomel Regional Clinical Hospital
Homyel, Belarus
University Hospital Banja Luka
Banja Luka, Bosnia and Herzegovina
Sveučilišna klinička bolnica
Mostar, Bosnia and Herzegovina
Prim.Dr. Abdulah Nakaš
Sarajevo, Bosnia and Herzegovina
Hospital Israelita Albert Einstein
São Paulo, Brazil
Beijing Hospital
Beijing, China
Guang An Men Hospital
Beijing, China
China West China Hospital
Chengdu, China
1st Affiliated Hospital of Guangzhou Medical University
Guangzhusi, China
Anhui Province Hospital
Hefei, China
China Shanghai Changhai Hospital
Shanghai, China
Tianjin First Center Hospital
Tianjin, China
KBC Rijeka
Rijeka, Croatia
Centro De Diagnostica Imagenes Medicina Avanzada y Telemedicina CEDIMAT
Santo Domingo, Dominican Republic
Kasturba Hospital
Manial, Karnataka, India
Lok Nayak Hospital
New Delhi, National Capital Territory of Delhi, India
Ispat General Hospital
Raurkela, Odisha, India
St James Hosptial
Dublin, Ireland
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ)
Mexico City, Mexico
Central State University Hospital
Ulaanbaatar, Mongolia
Shaukat Khanum Memorial Cancer Hospital and Research Center
Lahore, Pakistan
St. Luke's Medical Center
Manila, Philippines
The Med City Hospital
Manila, Philippines
Heliodor Swiecicki Clinical Hospital at the Karol Marcinkowski Medical University in Poznań
Poznan, Poland
King Abdulaziz Medical City,
Riyadh, Saudi Arabia
Military Medical Academy
Belgrade, Serbia
The Institute for pulmonary diseases of Vojvodina
Kamenitz, Serbia
Akdeniz University Hospital
Antalya, Turkey (Türkiye)
Gulhane Military Medical Faculty
Antalya, Turkey (Türkiye)
International hospital Kampala
Kampala, Uganda
Related Publications (2)
Tekin A, Swart P, Flurin L, Vukoja M, Kashyap R, Schultz MJ, Gajic O, Dong Y; CERTAIN investigators of the Society of Critical Care Medicine Discovery Network. The Weekend Effect on Evidence-Based Care Adherence Before and After Implementation of Checklist-Based Care in the Intensive Care Unit: A Multinational Study. J Intensive Care Med. 2025 Nov 24:8850666251396016. doi: 10.1177/08850666251396016. Online ahead of print.
PMID: 41284657DERIVEDVukoja M, Dong Y, Adhikari NKJ, Schultz MJ, Arabi YM, Martin-Loeches I, Hache M, Gavrilovic S, Kashyap R, Gajic O; Checklist for Early Recognition and Treatment of Acute Illness and Injury (CERTAIN) Investigators of the SCCM Discovery Network. Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable Resources. Crit Care Med. 2021 Jun 1;49(6):e598-e612. doi: 10.1097/CCM.0000000000004937.
PMID: 33729718DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ognjen Gajic, MD
Mayo Clinic
- PRINCIPAL INVESTIGATOR
Marija Kojicic, MD
Institute for Pulmonary Diseases, Novi Sad, Serbia
- STUDY DIRECTOR
Rahul Kashyap, MD
Mayo Clinic
- PRINCIPAL INVESTIGATOR
Marcus Schultz, MD
University of Amsterdam
- PRINCIPAL INVESTIGATOR
Michelle N Gong, MD
Montefiore Medical Center, New York USA
- PRINCIPAL INVESTIGATOR
Oguz Kilickaya, MD
Gulhane Military Medical Faculty, Ankara, Turkey
- PRINCIPAL INVESTIGATOR
Neill Adhikari, MD
University of Toronto, Toronto Canada
- PRINCIPAL INVESTIGATOR
Linda Bucher, PhD
College of Health Sciences, University of Delavere, Delawere USA
- PRINCIPAL INVESTIGATOR
Daniel Talmor, MD
Beth Israel Deakoness Medical Center, Boston USA
- STUDY DIRECTOR
Yue Dong, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- CONS-CRITICAL CARE
Study Record Dates
First Submitted
October 23, 2013
First Posted
November 1, 2013
Study Start
November 1, 2013
Primary Completion
December 1, 2017
Study Completion
March 1, 2018
Last Updated
August 20, 2018
Record last verified: 2018-08